EMEA-001115-PIP01-10-M07
Key facts
| Invented name |
Adasuve
|
| Active substance |
loxapine
|
| Therapeutic area |
Psychiatry
|
| Decision number |
P/0385/2019
|
| PIP number |
EMEA-001115-PIP01-10-M07
|
| Pharmaceutical form(s) |
Inhalation powder, pre-dispensed
|
| Condition(s) / indication(s) |
|
| Route(s) of administration |
Inhalation use
|
| Contact for public enquiries |
Ferrer Internacional S.A.
E-mail: lmoya@ferrer.com, agrima@ferrer.com, smartin@ferrer.com |
| Decision type |
PM: decision on the application for modification of an agreed PIP
|